We are live on ! Find out more
AC

Athanor Capital Portfolio holdings

AUM $24.6M
1-Year Est. Return 2.49%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+2.49%
3 Year Est. Return
+171.12%
5 Year Est. Return
+304.82%
10 Year Est. Return
AUM
$780M
AUM Growth
+$181M
Cap. Flow
+$153M
Cap. Flow %
19.67%
Top 10 Hldgs %
41.76%
Holding
156
New
91
Increased
29
Reduced
21
Closed
15

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$29.5M
2
NFLX icon
Netflix
NFLX
+$18.4M
3
MPC icon
Marathon Petroleum
MPC
+$16.8M
4
BABA icon
Alibaba
BABA
+$14.8M
5
MA icon
Mastercard
MA
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 21.51%
2 Communication Services 13.51%
3 Consumer Discretionary 9.86%
4 Financials 7.77%
5 Healthcare 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARX
101
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$409K 0.05%
+13,600
New +$312K
KURA icon
102
Kura Oncology
KURA
$800M
$394K 0.05%
+20,000
New +$332K
ARQL
103
DELISTED
Arqule Inc
ARQL
$392K 0.05%
+35,600
New +$248K
APLS
104
DELISTED
Apellis Pharmaceuticals
APLS
$385K 0.05%
+15,200
New +$309K
STNE icon
105
StoneCo
STNE
$2.77B
$349K 0.04%
+11,800
New +$347K
LOW icon
106
Lowe's Companies
LOW
$117B
$343K 0.04%
+3,400
New +$359K
YELP icon
107
Yelp
YELP
$1.45B
$338K 0.04%
+9,900
New +$342K
MRUS
108
DELISTED
Merus
MRUS
$334K 0.04%
+22,785
New +$324K
ZGNX
109
DELISTED
Zogenix, Inc.
ZGNX
$320K 0.04%
+6,700
New +$270K
LSXMK
110
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$304K 0.04%
+10,504
New +$307K
THOR
111
DELISTED
Synthorx, Inc. Common Stock
THOR
$290K 0.04%
+21,458
New +$344K
UNVR
112
DELISTED
Univar Solutions Inc.
UNVR
$289K 0.04%
+13,100
New +$286K
PRSP
113
DELISTED
Perspecta Inc. Common Stock
PRSP
$288K 0.04%
+12,300
New +$276K
DXC icon
114
DXC Technology
DXC
$1.82B
$281K 0.04%
+5,100
New +$295K
AYX
115
DELISTED
Alteryx Inc
AYX
$273K 0.04%
+2,500
New +$228K
TTD icon
116
Trade Desk
TTD
$8.48B
$251K 0.03%
+11,000
New +$236K
RETA
117
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$245K 0.03%
+2,600
New +$224K
QSR icon
118
Restaurant Brands International
QSR
$25.7B
$243K 0.03%
+3,500
New +$234K
CYTK icon
119
Cytokinetics
CYTK
$10.5B
$242K 0.03%
+21,500
New +$207K
RACE icon
120
Ferrari
RACE
$69.2B
$242K 0.03%
+1,500
New +$216K
AXSM icon
121
Axsome Therapeutics
AXSM
$11.2B
$237K 0.03%
+9,200
New +$184K
ACIU icon
122
AC Immune
ACIU
$223M
$234K 0.03%
+42,100
New +$215K
DRNA
123
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$233K 0.03%
+14,800
New +$201K
LNW
124
DELISTED
Light & Wonder
LNW
$222K 0.03%
+11,200
New +$232K
AXNX
125
DELISTED
Axonics, Inc. Common Stock
AXNX
$221K 0.03%
+5,400
New +$152K

Similar funds

Athanor Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Athanor Capital held 156 positions worth $780M, up 30% from $599M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Athanor Capital deployed $153M of net new capital in Q2 2019, opening 91 new positions and adding to 29 existing holdings. Its largest new stake was Anadarko Petroleum: 439,700 shares worth $31M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $11.7M trimmed.

  • Athanor Capital's largest Q2 2019 buy was Anadarko Petroleum: 439,700 shares worth $31M.
  • Athanor Capital added most to Netflix in Q2 2019, an estimated $18.4M increase.
  • Athanor Capital's biggest Q2 2019 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $11.7M.
  • Athanor Capital fully exited Eli Lilly in Q2 2019, selling an estimated $16.8M.
  • Athanor Capital's ten largest holdings make up 42% of its $780M portfolio in Q2 2019.
  • Athanor Capital opened 91 new positions and closed 15 in Q2 2019.
  • Athanor Capital's portfolio value rose 30% quarter-over-quarter to $780M.

Based on Athanor Capital's 13F filing for Q2 2019, filed 13 Aug 2019.